Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmacorp Rx Inc. ( (TSE:PCRX) ) has provided an announcement.
PharmaCorp Rx Inc. has announced a definitive agreement to acquire a PharmaChoice Canada bannered pharmacy in Ontario for $5.3 million, marking its first acquisition under its charter company structure. Additionally, the company has entered into a non-binding letter of intent to acquire two more pharmacies in Atlantic Canada for approximately $6.48 million. These acquisitions align with PharmaCorp’s strategy of growth through acquisitions and are expected to enhance its earnings. The company has also provided updates on previously announced transactions and remains committed to expanding its national presence.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates in the pharmaceutical industry, focusing on the acquisition and management of pharmacy businesses. The company is involved in expanding its footprint through strategic acquisitions, particularly under the PharmaChoice Canada banner, and aims to deliver long-term value to its shareholders.
Average Trading Volume: 27,663
Technical Sentiment Signal: Hold
Current Market Cap: C$54.16M
See more data about PCRX stock on TipRanks’ Stock Analysis page.